Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei and appendix tumours in elderly patients: Is it justified?

V. López-López,P.A. Cascales-Campos,E. Gil,J. Arevalo,A. Gonzalez,J. Gil,F.C. Muñoz-Casares,Juan Torres Melero,P. Barrios,R. Morales,I. Ramos,G Ortega,B. Camps,L. Gonzalez-Bayon,P Bretcha Boix,J. Farré Alegre,Santiago González Moreno,Pascual Parrilla

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei and appendix tumours in elderly patients: Is it justified?

2017

V. López-López
P.A. Cascales-Campos
E. Gil
J. Arevalo
A. Gonzalez
J. Gil
F.C. Muñoz-Casares
Juan Torres Melero
P. Barrios
R. Morales
I. Ramos
G Ortega
B. Camps
L. Gonzalez-Bayon
P Bretcha Boix
J. Farré Alegre
Santiago González Moreno
Pascual Parrilla

Background Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for pseudomyxoma peritonei and appendix tumours are widespread in the world. It is unclear what should be the attitude in elderly patients.

Keywords:

Pathology
Hyperthermic intraperitoneal chemotherapy
General surgery
Appendix
Medicine
Pseudomyxoma peritonei
Surgery
Combined Modality Therapy
Peritoneal Neoplasm
Cytoreduction Surgical Procedures
Retrospective cohort study
Survival rate

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations